Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Sees Large Growth in Short Interest

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) was the target of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling 40,613 shares, an increase of 122.6% from the February 12th total of 18,241 shares. Based on an average trading volume of 19,105 shares, the days-to-cover ratio is presently 2.1 days. Currently, 4.5% of the shares of the stock are short sold. Currently, 4.5% of the shares of the stock are short sold. Based on an average trading volume of 19,105 shares, the days-to-cover ratio is presently 2.1 days.

Virtus LifeSci Biotech Clinical Trials ETF Stock Down 0.9%

Shares of BBC opened at $42.96 on Thursday. Virtus LifeSci Biotech Clinical Trials ETF has a 1 year low of $13.42 and a 1 year high of $44.10. The business’s 50 day simple moving average is $41.01 and its 200-day simple moving average is $34.69.

Virtus LifeSci Biotech Clinical Trials ETF Company Profile

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.